Studies on the synthesis of aryl ethers using arene-manganese chemistry
摘要:
Selective arylation of polyfunctional phenols, using chlorobenzene- and p-chlorotoluene-manganese tricarbonyl cations, is described. The intermediate arene-manganese complexes are found to undergo stereo- and regioselective reactions with Schollkopf's chiral glycine enolate equivalent to give dienyl-Mn(CO)3 complexes. Treatment of these complexes with N-bromosuccinimide at room temperature, followed by hydrolysis of the dihydropyrazine, gives diaryl ethers in which one of the aromatic rings is an arylglycine methyl ester.
Studies on the synthesis of aryl ethers using arene-manganese chemistry
摘要:
Selective arylation of polyfunctional phenols, using chlorobenzene- and p-chlorotoluene-manganese tricarbonyl cations, is described. The intermediate arene-manganese complexes are found to undergo stereo- and regioselective reactions with Schollkopf's chiral glycine enolate equivalent to give dienyl-Mn(CO)3 complexes. Treatment of these complexes with N-bromosuccinimide at room temperature, followed by hydrolysis of the dihydropyrazine, gives diaryl ethers in which one of the aromatic rings is an arylglycine methyl ester.
New cyclic peptides via ring-closing metathesis reactions and their anti-bacterial activities
作者:Timothy P. Boyle、John B. Bremner、Jonathan Coates、John Deadman、Paul A. Keller、Stephen G. Pyne、David I. Rhodes
DOI:10.1016/j.tet.2008.09.031
日期:2008.12
As part of a program investigating cyclic peptides with an internal aromatic hydrophobic scaffold as potential novel anti-bacterial agents, we explored the synthesis of simple tyrosine-based systems. These were prepared via key intermediates containing internal allylglycine and allyltyrosine residues for subsequent ring-closingmetathesis reactions. Although the resulting anti-bacterial activity against
chiral phosphinite 1,2,5,6-di-isopropylidene-3,4-bis(diphenylphosphino)-D-mannitol was prepared and its rhodium complex was found to be an effective catalyst for the asymmetrichydrogenation of amidoacrylic acid and its derivatives with product ee's ranging from 90% to 97%.
The present invention is directed to compositions comprising lysophosphatidic acid analogs and methods of using such analogs as agonist or antagonists of LPA receptor activity. In addition the invention is directed to LPA receptor agonists that vary in the degree of selectivity at individual LPA receptors (i.e. LPA1, LPA2 and LPA3). More particularly the present invention is directed to LPA analogs wherein the glycerol is replaced with ethanolamine and a variety of substitutions have been linked at the second carbon atom.
The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.
The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.